Background End stage heart failure is a major cause of morbidity and mortality, and its
prevalence is expected to rise with the ageing population. For suitable patients, orthotopic …

Abstract Background: The HeartMate 3 left ventricular assist system (LVAS) is intended to
provide long-term support to patients with advanced heart failure. The centrifugal flow pump …

Abstract Background The HeartMate 3 Left Ventricular Assist System (LVAS)(St. Jude
Medical Inc., St Paul, MN) with full magnetic levitation allows for wide and consistent blood …

Aim This study aimed to assess safety and outcomes of patients, 2 years after implantation
with the HeartMate 3 Left Ventricular Assist System. Methods and results This study included …

Background The current study sought to demonstrate the advantages offered by fluorine 18-
fluorodeoxyglucose (18 F-FDG) positron emission tomography/computed tomography …

NUMEROUS PUBLICATIONS each year report focused analyses of various aspects of the
continuously growing data set regarding patients supported by durable left ventricular assist …

Aim Presence and consequent extent of infection in patients on continuous-flow left
ventricular assist devices (CF-LVADs) can be challenging with the current diagnostic tools …

Left ventricular assist devices (LVADs) are fast becoming standard of care for patients with
advanced heart failure. However, despite continuous improvement in VAD technology, there …

Background This study examined whether aortic valve opening (AVO) and other
echocardiographic parameters influence outcomes in patients on left ventricular (LV) assist …

Purpose A continuous-flow left ventricular assist device (LVAD) is a new and highly
promising therapy in supporting end-stage heart failure patients, either bridging them to …